GroupKALSHI

Event GroupKALSHIFinancials

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Total Volume

$0.00

Events

Markets

Trade on Kalshi

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Vol

$0.00

Events

Markets

Kalshi

Platform StatsQuick Platform Comparison

Polymarket

markets · $0.00

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Price ChartMatched Markets Price Graph

5 markets tracked

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

No data available

Single-Platform Markets(5)

Market	Platform	Price
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)	Kalshi	77%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))	Kalshi	10%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)	Kalshi	9%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)	Kalshi	7%
What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)	Kalshi	3%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

77%

Top Probability

$0.00

Volume

Markets

Platforms

About This Event

FDA decision on Gedatolisib in July 2026 If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is X before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026 This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Friday, July 10, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
**Category:** Financials | **Status:** active
**Resolution Date:** N/A (Unknown)
**Time Pressure:** Unknown

**Description:** FDA decision on Gedatolisib in July 2026

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is X before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026 This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

**Resolution Criteria (Sample):**
"If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Withdrawn by Sponsor before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026"

## 2. Market liquidity & Volume
* **Total Volume:** $0
* **Total Liquidity:** $0
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.00)

## 3. Market Data (Prices & Odds)
### 1. What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)
- **Kalshi** (End: Aug 8, 2026): Vol $0
  DATA: [Yes: 2.5% (0.0%)] | [No: 97.5% (0.0%)]

### 2. What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)
- **Kalshi** (End: Aug 8, 2026): Vol $0
  DATA: [Yes: 6.5% (0.0%)] | [No: 93.5% (0.0%)]

### 3. What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)
- **Kalshi** (End: Aug 8, 2026): Vol $0
  DATA: [Yes: 76.5% (0.0%)] | [No: 23.5% (0.0%)]

### 4. What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))
- **Kalshi** (End: Aug 8, 2026): Vol $0
  DATA: [Yes: 9.5% (0.0%)] | [No: 90.5% (0.0%)]

### 5. What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)
- **Kalshi** (End: Aug 8, 2026): Vol $0
  DATA: [Yes: 8.5% (0.0%)] | [No: 91.5% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

KALSHIFinancials

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Volume$0.00

Markets5

5 of 5

Sort:

KALSHI

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

KALSHI

KKalshi

Yes 76.5¢No 23.5¢

KALSHIHealth

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Full Approval before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

KALSHI

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

KALSHI

KKalshi

Yes 9.5¢No 90.5¢

KALSHIHealth

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Denied (CRL Issued) before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

KALSHI

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

KALSHI

KKalshi

Yes 8.5¢No 91.5¢

KALSHIHealth

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Conditional / Accelerated Approval before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

KALSHI

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

KALSHI

KKalshi

Yes 6.5¢No 93.5¢

KALSHIHealth

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is No Decision before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

KALSHI

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

KALSHI

KKalshi

Yes 2.5¢No 97.5¢

KALSHIHealth

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Withdrawn by Sponsor before Aug 1, 2026, the market resolves to Yes. Early close condition: This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026

No related news found

Discussion

0 Comments

Market Insights

Average Yes Price

21¢

Kalshi

Arbitrage Opps

Cross-Platform

Embed Widget

Add this market to your website

Volume

Platforms

HTML

<iframe src="https://predictpedia.com/embed/Sejf_n" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="FDA decision: Gedatolisib by Celcuity Inc. (July 2026)"></iframe>

Trade This Market

Trade on Kalshi

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

AI Analysis

About This Event

Custom AI Analysis Prompt

Educational Context

Events (1)

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Markets (5)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

Related News & Context

Discussion

Market Insights

Share

Embed Widget

Trade This Market

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

Custom AI Analysis Prompt

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Full Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Denied (CRL Issued))

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Conditional / Accelerated Approval)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (No Decision)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

What will the FDA's decision be on Gedatolisib by Celcuity Inc. in July 2026? (Withdrawn by Sponsor)

Related News & Context

Discussion

Share

Embed Widget